Document Detail


Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition.
MedLine Citation:
PMID:  19556043     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Nephrotic syndrome is defined as urine total protein excretion greater than 3.5 g/d or total protein-creatinine ratio greater than 3.5 g/g, low serum albumin level, high serum cholesterol level, and peripheral edema. These threshold levels have not been rigorously evaluated in patients with diabetic kidney disease or by using urine albumin excretion, the preferred measure of proteinuria in patients with diabetes.
STUDY DESIGN: Diagnostic test study.
SETTING & PARTICIPANTS: Adults with type 2 diabetes, hypertension, and urine total protein level greater than 0.9 g/d enrolled in the Irbesartan in Diabetic Nephropathy Trial.
INDEX TEST: Baseline measures of proteinuria (total protein and albumin excretion and protein-creatinine and albumin-creatinine ratios). Linear regression to relate measures.
REFERENCE TEST: Other signs and symptoms of nephrotic syndrome at baseline (serum albumin < 3.5 g/dL, serum total cholesterol > 260 mg/dL or use of a statin, and edema or use of a loop diuretic); progression of chronic kidney disease during follow-up (doubling of baseline serum creatinine level or requirement for dialysis or kidney transplantation). Logistic regression to relate index and reference tests.
RESULTS: In 1,608 participants, total urine protein level of 3.5 g/d was equivalent to urine albumin level of 2.2 g/d (95% confidence interval, 1.4 to 3.5). Of 1,467 participants, 641 (44%) had urine total protein level of 3.5 g/d or greater at baseline, 132 (9%) had other signs and symptoms of nephrotic syndrome at baseline, and 385 (26%) had progression of kidney disease during a mean follow-up of 2.6 years. Areas under the receiver operating curves for measures of proteinuria were 0.80 to 0.83 for other signs and symptoms of nephrotic syndrome and 0.72 to 0.74 for kidney disease progression. Threshold levels for nephrotic-range proteinuria and albuminuria were close to the points of maximal accuracy for both outcomes.
LIMITATIONS: Study population limits generalizability; inability to adjust for several variables known to affect serum albumin levels; lack of spot urine samples.
CONCLUSIONS: The historical definition of nephrotic-range proteinuria appears reasonable in patients with diabetic kidney disease. Equivalent thresholds for nephrotic-range albuminuria and albumin-creatinine ratio are 2.2 g/d and 2.2 g/g, respectively.
Authors:
Nicholas Stoycheff; Lesley A Stevens; Christopher H Schmid; Hocine Tighiouart; Julia Lewis; Robert C Atkins; Andrew S Levey
Related Documents :
22309583 - Update on gestational diabetes mellitus.
19887833 - Is cystatin c a useful marker in the detection of diabetic kidney disease?
9881813 - Intracellular starvation in the insulin resistance syndrome and type ii diabetes mellitus.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2009-06-25
Journal Detail:
Title:  American journal of kidney diseases : the official journal of the National Kidney Foundation     Volume:  54     ISSN:  1523-6838     ISO Abbreviation:  Am. J. Kidney Dis.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-26     Completed Date:  2009-11-16     Revised Date:  2012-03-05    
Medline Journal Info:
Nlm Unique ID:  8110075     Medline TA:  Am J Kidney Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  840-9     Citation Subset:  IM    
Affiliation:
Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA. nstoycheff@tuftsmedicalcenter.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Albuminuria / urine
Creatinine / urine
Diabetic Nephropathies / diagnosis*,  urine
Disease Progression
Female
Humans
Male
Middle Aged
Nephrotic Syndrome / diagnosis*,  urine
Grant Support
ID/Acronym/Agency:
K23 DK081017-05/DK/NIDDK NIH HHS; T32 DK07777/DK/NIDDK NIH HHS; U01 DK053869/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
60-27-5/Creatinine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Idiopathic nephrotic syndrome and atopy: is there a common link?
Next Document:  Behavioral management of headache triggers: Avoidance of triggers is an inadequate strategy.